7 celebs who lost their lives to pancreatic cancer
Key Takeaways
R&B legend Michael “D’Angelo” Archer’s recent death from pancreatic cancer at age 51 underscores the disease’s devastating trajectory and the ongoing clinical challenges in early detection and management. Below: 7 legends lost to pancreatic cancer.
R&B icon Michael “D’Angelo” Archer died at age 51 after a private battle with pancreatic cancer on October 14, 2025.[]
D’Angelo had been hospitalized for months and entered hospice care in his final days, according to news reports.[]
Pancreatic cancer is the third leading cause of cancer death in the US—and it has one of the lowest survival rates.[] For clinicians, D’Angelo’s death reinforces persistent challenges in pancreatic oncology: late detection, a lack of early biomarkers, and limited therapeutic breakthroughs. Even among high-profile cases, the disease often remains undetected until it is in advanced stages.
Below: Six of your favorite celebrities who have passed from pancreatic cancer over the years—and what clinicians can take away from each tragic case.
Patrick Swayze
Dirty Dancing actor Patrick Swayze was diagnosed with stage IV pancreatic cancer in 2008.[] He underwent chemotherapy and was enrolled in an experimental trial for vatalanib, an anti-angiogenic small molecule aimed at blocking blood flow to tumors.[][] Despite initial optimism, his disease progressed, including metastases to the liver. He died 20 months after diagnosis.[]
Clinician Takeaways
Swayze’s case serves as a cautionary tale: Despite the use of early anti-angiogenic strategies, the heterogeneity and dense stromal microenvironment of pancreatic tumors make such approaches difficult to sustain. The gap between biological plausibility and clinical benefit remains wide in this disease space.
Alex Trebek
Jeopardy! host Alex Trebek announced in March 2019 that he had stage IV pancreatic cancer; he passed in November 2020 at age 80.[][]
Trebek was remarkably public about his journey—he continued to host episodes, update fans, and raise awareness while in treatment.[] This openness helped shine a spotlight on patient experience, treatment tolerance, and the emotional burden of living with aggressive cancer.
Clinician Takeaways
Trebek’s case underscores the psychosocial dimension of pancreatic cancer care. Patient advocacy, transparency about disease trajectory, and quality-of-life considerations are as important as the next chemo regimen.
Willie Garson
Actor Willie Garson, best known for portraying Stanford Blatch on Sex and the City, died in 2021 at age 57 from pancreatic cancer.[]
Though his story is less documented, his death added to growing awareness that pancreatic cancer affects a wide demographic and may present quietly.
Clinician Takeaways
Garson’s case is a somber reminder that even younger patients—those in their 50s—can harbor this disease. Emphasis should remain on investigating subtle but persistent symptoms—even in otherwise healthy-seeming adults—and considering risk stratification protocols.
Michael Landon
Best known for his roles on Bonanza and Little House on the Prairie, Michael Landon was diagnosed with pancreatic cancer in April 1991 and died in July of the same year, at age 54.[]
Clinician Takeaways
Landon’s disease was deemed inoperable from the start, and he passed just a few months after diagnosis.[] His daughter has since become active in pancreatic cancer awareness campaigns, often stating that her father’s rapid decline persuaded her to promote early discussion and genetic risk testing.[] This case speaks to the importance of early detection and genetic counseling.
Ruth Bader Ginsburg
Supreme Court Justice Ruth Bader Ginsburg died in 2020 of pancreatic cancer. She had previously been treated for colon cancer and undergone surgery for pancreatic cancer.[]
Clinician Takeaways
Justice Ginsburg's case illustrates sequential malignancies in a patient with cancer history and emphasizes the challenges of cumulative treatment burden. Her disease trajectory reinforces the need for vigilance and the difficulty of distinguishing recurrence, second primaries, or new pathology in patients under long-term surveillance.
Steve Jobs
Steve Jobs died in October 2011 at age 56. His case is distinct: he had a pancreatic neuroendocrine tumor, a rare form of pancreatic cancer.[]
What makes his case fascinating—and controversial—for clinicians:
Relative indolence vs delayed care: Jobs was diagnosed in late 2003, but he delayed conventional surgical intervention for approximately 9 months, pursuing alternative therapies first (eg, dietary supplements and acupuncture).[]
Surgery without adjuvant chemoradiation: Jobs reportedly underwent a Whipple procedure in mid-2004 and did not receive standard chemo or radiation afterward.[]
Long survival, then metastasis and liver transplant: Over several years, Jobs’ disease recurred, and in 2009, he underwent a liver transplant.[]
Tumor biology distinctions: Jobs’ neuroendocrine subtype allowed a more protracted natural history than typical pancreatic adenocarcinomas.
Clinician Takeaways
Jobs’ case highlights the diagnostic, ethical, and therapeutic tension in NET vs non-NET pancreatic tumors. It also raises debates around patient autonomy in delaying therapy, the role of alternative approaches, and lessons for when to intervene aggressively vs observe in slow-growing pancreatic lesions.